Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03515538
Title Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors EpicentRx, Inc.
Indications

oropharynx cancer

oral squamous cell carcinoma

Therapies

Cisplatin + RRx-001

RRx-001

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.